Princeton student’s possible adverse reaction to Bexsero: What is Rhabdomyolysis?
Just one week after Princeton University administered the second dose of the unlicensed meningococcal meningitis vaccine, Bexsero, and the week the University of California, Santa Barbara (UCSB) began giving the More...
Princeton vaccinates 4,361 with Bexsero with one clinic day left
Princeton University said Wednesday that more than 4,300 people received the first dose of the two-dose series of the meningococcal serogroup B vaccine after three days of clinic operations. Neisseria meningitidisImage/CDC As More...
Princeton announces dates for receiving meningitis B vaccine
The New Jersey university, which has experienced eight cases of serogroup B meningococcal disease since March, has announced the dates they will be administering the vaccine that helps protect against meningococcal More...
What is Bexsero? How common is meningococcal disease serogroup B?
With the eighth case of meningococcal meningitis confirmed at Princeton University yesterday, and at least seven confirmed as Neisseria meningitis serotype B (MenB) with the most recent still pending, health officials More...
Princeton hopes to make Bexsero available for students in December
In a follow-up to an earlier story, Princeton University announced today via email that they will be receiving the EU/Australia approved meningococcal meningitis vaccine, Bexsero, to offer to immunize students against More...
Princeton considers the use of Bexsero meningitis vaccine to curb spread of meningitis B
Following the seventh confirmed case of Neisseria meningitis B infection at Princeton University since March, the school is considering the use of a European Union/Australia -approved vaccine that will protect against More...
